Therapeutic strategies for a functional cure of chronic hepatitis B virus infection. - Wikidata - awgldk - TriplyDB

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

http://www.wikidata.org/entity/Q38636988

about

Early hepatitis B viral DNA clearance predicts treatment response at week 96 Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation.A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2.Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure The current status and future directions of hepatitis B antiviral drug discovery.Toward Elimination of Hepatitis B Virus Using Novel Drugs, Approaches, and Combined Modalities Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X.Characterization of novel hepadnaviral RNA species accumulated in hepatoma cells treated with viral DNA polymerase inhibitors HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation.Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161++TCR iVα7.2+ Mucosal-Associated Invariant T Cells in Chronic Hepatitis B Virus Infection.An OX40/OX40L interaction directs successful immunity to hepatitis B virus.Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates Structures of Hepatitis B Virus Core- and e-Antigen Immune Complexes Suggest Multi-point Inhibition Antiviral effects of hepatitis B virus S gene-specific anti-gene locked nucleic acid in transgenic mice

P2860

Q33628420-C905FF57-1AD0-4860-ACE5-F5A1879214F3 Q36207245-CC319681-3334-4290-A3D3-C6628332B0CD Q36376142-90C5675B-ADA9-4DB5-AC66-13FCD2B10E8F Q38553065-00DDA624-9771-4CAA-A190-48D696585EF2 Q38802098-A871A9B0-501E-4141-8108-B93485F0FB81 Q38980907-88872354-27EA-4B9F-BC69-D4977CC1DEE0 Q40178518-8F269158-6C80-4D6B-A837-AF102E3A4A42 Q40580426-32E8FF72-8D38-4A19-B0FB-302FDDB8AA92 Q40798098-50B7F9BC-353B-4EBF-A56B-2B78B3A98C53 Q41930702-8599D5E6-72C4-4120-BDF0-568A67D15110 Q52579748-F1C2B8F9-289E-4E10-93EC-9FBB07276843 Q52608541-3932BF8C-DBC3-4300-8C92-A6F487C96229 Q52644026-F6923918-A945-4732-9113-8B93C93B797A Q56989931-B434EBB6-22F3-4189-BAF9-40D3E997EE87 Q57050752-FA6BA853-2052-49C6-AA1D-0FE0D10C9F97 Q58773525-F82AE65E-956E-4B10-82F8-52549C3F9821

P2860

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

http://www.wikidata.org/entity/Q38636988

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

@en

type

label

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

@en

prefLabel

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

@en

P1433

Q38636988-8E8CE396-19A6-41A8-93F9-0E834F91D5AB

P1476

Q38636988-754D48FF-7C43-4CFE-A74B-D473F3E9E7FE

P2093

Q38636988-02C09F89-98F5-453E-BB4D-59045B570F8B

Q38636988-49480795-5CD4-4201-B992-DF3F9F3D6864

Q38636988-49736779-86D0-4414-83F4-BBAB4CF33EBD

Q38636988-9D0A8136-F31A-4297-8AD7-52524058CC39

P2860

Q38636988-024E5E9A-CC8B-4AE8-9E49-5F83797E4533

Q38636988-04A98CD0-825B-42D7-8B9B-F029BCFE36B4

Q38636988-05AFED41-8E64-4A7A-9597-954E71BE286A

Q38636988-0665F3DB-6B09-47AD-8AB8-0EDC90EBB69D

Q38636988-0EDE586C-A5C8-4358-9DFF-B760D4963A00

Q38636988-110972E4-AEB5-48BB-AEA0-389FBC00DE6D

Q38636988-116080E1-E7F8-438B-A824-7BFAA88C1EB4

Q38636988-13D5CE08-43AF-4959-A96E-48AFA2F48D5D

Q38636988-1797DFEF-B36A-446C-B5D5-5345BE322990

Q38636988-181D5732-38D9-46B5-9794-3C00DD5188AB

P304

Q38636988-DF8A7E13-013A-4774-A0B3-41DF78216E5A

P31

Q38636988-C9906536-CE26-4D07-AF13-7AA37E88521A

P356

Q38636988-0A857511-384C-47DF-89FD-7569154D59FC

P433

Q38636988-EA9B0CFB-9378-4FE0-B8FC-61EA694DC3B0

P478

Q38636988-F9DBCE9E-0F52-41A2-8BBE-810373A86001

P577

Q38636988-9923FC5F-F390-4860-9255-137A5CDCC17A

P5875

Q38636988-E0C3F6F1-DF3A-4962-B4F4-3A05BBD4192A

P698

Q38636988-ED8CD84E-A8C8-4CB2-BCD0-6CF1E7250352

P932

Q38636988-6A45E95C-3128-40B0-BDDF-C5FD1EF90374

P356

J.APSB.2014.05.002

P1433

Acta pharmaceutica Sinica B

P1476

Therapeutic strategies for a functional cure of chronic hepatitis B virus infection.

@en

P2093

Fang Guo

http://www.w3.org/2001/XMLSchema#string

Jinhong Chang

http://www.w3.org/2001/XMLSchema#string

Ju-Tao Guo

http://www.w3.org/2001/XMLSchema#string

Xuesen Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine

Hepatitis B virus replication

Hepatitis B: the virus and disease

Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress

Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation

Immune responses to HCV and other hepatitis viruses

A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.APSB.2014.05.002

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263281592

http://www.w3.org/2001/XMLSchema#string

P698

26579392

http://www.w3.org/2001/XMLSchema#string

P932

4629125

http://www.w3.org/2001/XMLSchema#string